{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:00:01Z","timestamp":1765742401570},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The term multimorbidity is usually defined as the coexistence of two or more chronic conditions within an individual, whereas the term comorbidity traditionally describes patients with an index condition and one or more additional conditions. Multimorbidity of chronic conditions markedly worsens outcomes in patients, increases treatment burden and increases health service costs. Although patients with chronic respiratory disease often have physical comorbidities, they also commonly experience psychological problems such as depression and anxiety. Multimorbidity is associated with increased health-care utilisation and specifically with an increased number of prescription drugs in individuals with multiple chronic conditions such as chronic obstructive pulmonary disease. This <jats:italic>npj Primary Care Respiratory Medicine<\/jats:italic> Education Section case study involves a patient in a primary care consultation presenting several common diseases prevalent in people of this age. The patient takes nine different drugs at this moment, one or more pills for each condition, which amounts to polypharmacy. The problems related with polypharmacy recommend that a routine medication review by primary care physicians be performed to reduce the risk of adverse effects of polypharmacy among those with multiple chronic conditions. The primary care physician has the challenging role of integrating all of the clinical problems affecting the patient and reviewing all medicaments (including over-the-counter medications) taken by the patient at any point in time, and has the has the key to prevent the unwanted consequences of polypharmacy. Multimorbid chronic disease management can be achieved with the use of care planning, unified disease templates, use of information technology with appointment reminders and with the help of the wider primary care and community teams.<\/jats:p>","DOI":"10.1038\/npjpcrm.2016.43","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T10:58:52Z","timestamp":1473937132000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Managing multimorbidity in primary care in patients with chronic respiratory conditions"],"prefix":"10.1038","volume":"26","author":[{"given":"Deborah","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Agur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Eiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan I","family":"Gonz\u00e1lez-Montalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Gruffydd-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"BFnpjpcrm201643_CR1","unstructured":"Mercer, S. W., Salisbury, C. & Fortin, M. The ABC of Multimorbidity (Wiley-Blackwell, UK, 2014)."},{"key":"BFnpjpcrm201643_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/13814780802436093","volume":"14","author":"AA Uijen","year":"2008","unstructured":"Uijen, A. A. & van de Lisdonk, E. H. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur. J. Gen. Pract. 14, 28\u201332 (2008).","journal-title":"Eur. J. Gen. Pract."},{"key":"BFnpjpcrm201643_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380, 37\u201343 (2012).","journal-title":"Lancet"},{"key":"BFnpjpcrm201643_CR4","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan, C. et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE 9, e102149 (2014).","journal-title":"PLoS ONE"},{"key":"BFnpjpcrm201643_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni, A. et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res. Rev. 10, 430\u2013439 (2011).","journal-title":"Ageing Res. Rev."},{"key":"BFnpjpcrm201643_CR6","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1503\/cmaj.121349","volume":"185","author":"RA Payne","year":"2013","unstructured":"Payne, R. A., Abel, G. A., Guthrie, B. & Mercer, S. W. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. CMAJ 185, E221\u2013E228 (2013).","journal-title":"CMAJ"},{"key":"BFnpjpcrm201643_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/1471-2458-10-718","volume":"10","author":"AW Taylor","year":"2010","unstructured":"Taylor, A. W. et al. Multimorbidity - not just an older person's issue. Results from an Australian biomedical study. BMC Public Health 10, 718 (2010).","journal-title":"BMC Public Health"},{"key":"BFnpjpcrm201643_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3109\/02770900903350473","volume":"46","author":"T Zhang","year":"2009","unstructured":"Zhang, T., Carleton, B. C., Prosser, R. J. & Smith, A. M. The added burden of comorbidity in patients with asthma. J. Asthma 46, 1021\u20131026 (2009).","journal-title":"J. Asthma"},{"key":"BFnpjpcrm201643_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4104\/pcrj.2013.00107","volume":"23","author":"H Steppuhn","year":"2014","unstructured":"Steppuhn, H., Langen, U., Keil, T. & Scheidt-Nave, C. Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German Health Update (GEDA) 2009 and 2010. Prim. Care Respir. J. 23, 22\u201329 (2014).","journal-title":"Prim. Care Respir. J."},{"key":"BFnpjpcrm201643_CR10","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3399\/bjgp14X680545","volume":"64","author":"G McLean","year":"2014","unstructured":"McLean, G. et al. The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study. Br. J. Gen. Pract. 64, e440\u2013e447 (2014).","journal-title":"Br. J. Gen. Pract."},{"key":"BFnpjpcrm201643_CR11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1513\/AnnalsATS.201404-138OC","volume":"11","author":"T To","year":"2014","unstructured":"To, T. et al. Asthma deaths in a large provincial health system. A 10-year population-based study. Ann. Am. Thorac. Soc. 11, 1210\u20131217 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"BFnpjpcrm201643_CR12","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1378\/chest.123.5.1684","volume":"123","author":"RJ Halbert","year":"2003","unstructured":"Halbert, R. J., Isonaka, S., George, D. & Iqbal, A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 123, 1684\u20131692 (2003).","journal-title":"Chest"},{"key":"BFnpjpcrm201643_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","volume":"370","author":"DM Mannino","year":"2007","unstructured":"Mannino, D. M. & Buist, A. S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370, 765\u2013773 (2007).","journal-title":"Lancet"},{"key":"BFnpjpcrm201643_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.rmed.2010.07.019","volume":"105","author":"S O'Kelly","year":"2011","unstructured":"O'Kelly, S., Smith, S. M., Lane, S., Teljeur, C. & O'Dowd, T. Chronic respiratory disease and multimorbidity: prevalence and impact in a general practice setting. Respir. Med. 105, 236\u2013242 (2011).","journal-title":"Respir. Med."},{"key":"BFnpjpcrm201643_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/COPD.S24443","volume":"6","author":"FM Franssen","year":"2011","unstructured":"Franssen, F. M., Spruit, M. A. & Wouters, E. F. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 493\u2013501 (2011).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201643_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1183\/09031936.00133805","volume":"28","author":"DD Sin","year":"2006","unstructured":"Sin, D. D., Anthonisen, N. R., Soriano, J. B. & Agusti, A. G. Mortality in COPD: Role of comorbidities. Eur. Respir. J. 28, 1245\u20131257 (2006).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201643_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2049-6958-10-4","volume":"10","author":"G Fumagalli","year":"2015","unstructured":"Fumagalli, G. et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip. Respir. Med. 10, 4 (2015).","journal-title":"Multidiscip. Respir. Med."},{"key":"BFnpjpcrm201643_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1183\/09031936.00014814","volume":"44","author":"J Diez-Manglano","year":"2014","unstructured":"Diez-Manglano, J. et al. Polypharmacy in patients hospitalised for acute exacerbation of COPD. Eur. Respir. J. 44, 791\u2013794 (2014).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201643_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1164\/rccm.201003-0472OC","volume":"183","author":"NA Hanania","year":"2011","unstructured":"Hanania, N. A. et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am. J. Respir. Crit. Care Med. 183, 604\u2013611 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnpjpcrm201643_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","volume":"128","author":"JB Soriano","year":"2005","unstructured":"Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N. & Hansell, A. L. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128, 2099\u20132107 (2005).","journal-title":"Chest"},{"key":"BFnpjpcrm201643_CR21","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1038\/npjpcrm.2014.9","volume":"24","author":"D Price","year":"2014","unstructured":"Price, D., Fletcher, M. & van der Molen, T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim. Care Respir. Med. 24, 14009 (2014).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"BFnpjpcrm201643_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00127-010-0330-z","volume":"47","author":"JM Gunn","year":"2012","unstructured":"Gunn, J. M. et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc. Psychiatry Psychiatr. Epidemiol. 47, 175\u2013184 (2012).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"BFnpjpcrm201643_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2458-8-119","volume":"8","author":"SY Wong","year":"2008","unstructured":"Wong, S. Y., Mercer, S. W., Woo, J. & Leung, J. The influence of multi-morbidity and self-reported socio-economic standing on the prevalence of depression in an elderly Hong Kong population. BMC Public Health 8, 119 (2008).","journal-title":"BMC Public Health"},{"key":"BFnpjpcrm201643_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jaip.2014.06.020","volume":"2","author":"MA Rank","year":"2014","unstructured":"Rank, M. A. & Shah, N. D. Multiple chronic conditions and asthma: implications for practice and research. J. Allergy Clin. Immunol. Pract. 2, 518\u2013524 (2014).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"BFnpjpcrm201643_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.201105-0939PP","volume":"185","author":"C Laurin","year":"2012","unstructured":"Laurin, C., Moullec, G., Bacon, S. L. & Lavoie, K. L. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am. J. Respir. Crit. Care Med. 185, 918\u2013923 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnpjpcrm201643_CR26","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4088\/JCP.14m09147","volume":"75","author":"DJ Smith","year":"2014","unstructured":"Smith, D. J. et al. Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care. J. Clin. Psychiatry. 75, 1202\u20131208, quiz 8 (2014).","journal-title":"J. Clin. Psychiatry."},{"key":"BFnpjpcrm201643_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaci.2004.04.042","volume":"114","author":"KF Rabe","year":"2004","unstructured":"Rabe, K. F. et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J. Allergy Clin. Immunol. 114, 40\u201347 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnpjpcrm201643_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.aprim.2014.07.006","volume":"47","author":"MJ Bruscas Alijarde","year":"2015","unstructured":"Bruscas Alijarde, M. J., Naberan Tona, K., Lamban Sanchez, M. T. & Bello Dronda, S. [ARAPOC Study: Prevalence of respiratory symptoms and chronic obstructive pulmonary disease in the general population]. Aten. Primaria. 47, 336\u2013343 (2015).","journal-title":"Aten. Primaria."},{"key":"BFnpjpcrm201643_CR29","unstructured":"Chetty, U. et al. COPD and comorbidities: a cross- sectional analysis of 1.2 million patients from a nationally representative dataset in Scotland. (submitted)."},{"key":"BFnpjpcrm201643_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40248-015-0023-2","volume":"10","author":"RW Dal Negro","year":"2015","unstructured":"Dal Negro, R. W., Bonadiman, L. & Turco, P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip. Respir. Med. 10, 24 (2015).","journal-title":"Multidiscip. Respir. Med."},{"key":"BFnpjpcrm201643_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","volume":"186","author":"M Divo","year":"2012","unstructured":"Divo, M. et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186, 155\u2013161 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnpjpcrm201643_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1370\/afm.1683","volume":"12","author":"AJ Trachtenberg","year":"2014","unstructured":"Trachtenberg, A. J., Dik, N., Chateau, D. & Katz, A. Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a canadian city. Ann. Fam. Med. 12, 402\u2013407 (2014).","journal-title":"Ann. Fam. Med."},{"key":"BFnpjpcrm201643_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/bmj.b2803","volume":"339","author":"C May","year":"2009","unstructured":"May, C., Montori, V. M. & Mair, F. S. We need minimally disruptive medicine. Br. Med. J. 339, 485\u2013487 (2009).","journal-title":"Br. Med. J."},{"key":"BFnpjpcrm201643_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/1471-2458-10-718","volume":"10","author":"AW Taylor","year":"2010","unstructured":"Taylor, A. W. et al. Multimorbidity: not just an older person\u2019s issue. Results from an Australian biomedical study. BMC Public Health 10, 718 (2010).","journal-title":"BMC Public Health"},{"key":"BFnpjpcrm201643_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5694\/mja14.00146","volume":"201","author":"IA Scott","year":"2014","unstructured":"Scott, I. A., Anderson, K., Freeman, C. R. & Stowasser, D. A. First do no harm: a real need to deprescribe in older patients. Med. J. Aust 201, 390\u2013392 (2014).","journal-title":"Med. J. Aust"},{"key":"BFnpjpcrm201643_CR36","doi-asserted-by":"crossref","unstructured":"Wouters M. Economic analysis of the Confronting survey: an overview of results. Respir. Med. 97, S3\u2013S14 (2003).","DOI":"10.1016\/S0954-6111(03)80020-3"},{"key":"BFnpjpcrm201643_CR37","doi-asserted-by":"crossref","unstructured":"Franssen F. M. E., Spruit M. A. & Wouters E. F. M. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 493\u2013501 (2011).","DOI":"10.2147\/COPD.S24443"},{"key":"BFnpjpcrm201643_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1532-5415.2009.02131.x","volume":"57","author":"M Wehling","year":"2009","unstructured":"Wehling, M. Multimorbidity and polypharmacy\/how to reduce the harmful drug load and yet add needed drugs in the elderly?proposal off a new drug classification\/fit for the aged. J. Am. Geriatr. Soc. 57, 560\u2013561 (2009).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnpjpcrm201643_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/fampra\/cms070","volume":"30","author":"D Koper","year":"2013","unstructured":"Koper, D., Kamenski, G., Flamm, M., B\u00f6hmdorfera, B. & S\u00f6nnichsena, A. Frequency of medication errors in primary care patients with polypharmacy. Fam. Pract. 30, 313\u2013319 (2013).","journal-title":"Fam. Pract."},{"key":"BFnpjpcrm201643_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40266-015-0242-4","volume":"32","author":"J Fastbom","year":"2015","unstructured":"Fastbom, J. & Johnell, K. National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging 32, 189\u2013199 (2015).","journal-title":"Drugs Aging"},{"key":"BFnpjpcrm201643_CR41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1365-2125.2009.03531.x","volume":"68","author":"C Ryan","year":"2009","unstructured":"Ryan, C., O\u2019Mahony, D., Kennedy, J., Weedle, P. & Byrne, S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br. J. Clin. Pharmacol. 68, 936\u2013947 (2009).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnpjpcrm201643_CR42","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","unstructured":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 60, 616\u2013631 (2012).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnpjpcrm201643_CR43","first-page":"129","volume":"21","author":"S Berryman","year":"2012","unstructured":"Berryman, S. & Jennings, J. Beers criteria for potentially inappropriate medication use in older adults. Medsurg. Nurs. 21, 129\u2013134 (2012).","journal-title":"Medsurg. Nurs."},{"key":"BFnpjpcrm201643_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony, D. et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44, 213\u2013218 (2015).","journal-title":"Age Ageing"},{"key":"BFnpjpcrm201643_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ageing\/afn197","volume":"37","author":"P Gallagher","year":"2008","unstructured":"Gallagher, P. & O\u2019Mahony, D. STOPP (Screening Tool of Older Persons\u2019 potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 37, 673\u2013679 (2008).","journal-title":"Age Ageing"},{"key":"BFnpjpcrm201643_CR46","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/pds.1829","volume":"18","author":"MN Ilhan","year":"2009","unstructured":"Ilhan, M. N. et al. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma\/COPD medication. Pharmacoepidemiol. Drug Saf. 18, 1150\u20131157 (2009).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"BFnpjpcrm201643_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/thx.2007.086041","volume":"63","author":"J Bourbeau","year":"2008","unstructured":"Bourbeau, J. & Bartlett, S. J. Patient adherence in COPD. Thorax 63, 831\u2013838 (2008).","journal-title":"Thorax"},{"key":"BFnpjpcrm201643_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4104\/pcrj.2009.00062","volume":"19","author":"W Vincken","year":"2010","unstructured":"Vincken, W., Dekhuijzen, R. & Barnes, P. The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim. Care Respir. J. 19, 10\u201320 (2010).","journal-title":"Prim. Care Respir. J."},{"key":"BFnpjpcrm201643_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni, A. A. & Jackson, S. H. D. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br. J. Clin. Pharmacol. 57, 6\u201314 (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnpjpcrm201643_CR50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.5114\/aoms.2014.46212","volume":"5","author":"T Roblek","year":"2014","unstructured":"Roblek, T., Trobec, K., Mrhar, A. & Lainscak, M. Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease. Arch. Med. Sci. 5, 920\u2013932 (2014).","journal-title":"Arch. Med. Sci."},{"key":"BFnpjpcrm201643_CR51","first-page":"331","volume":"87","author":"RW Pretorius","year":"2013","unstructured":"Pretorius, R. W., Gataric, G., Swedlund, S. K. & Miller, J. R. Reducing the risk of adverse drug events in older adults. Am. Fam. Physician 87, 331\u2013336 (2013).","journal-title":"Am. Fam. Physician"},{"key":"BFnpjpcrm201643_CR52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-149-6-200809160-00004","volume":"149","author":"TA Lee","year":"2008","unstructured":"Lee, T. A., Pickard, A. S., Au, D. H., Bartle, B. & Weiss, K. B. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann. Intern. Med. 149, 380\u2013390 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnpjpcrm201643_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/COPD.S4620","volume":"4","author":"DE Hilleman","year":"2009","unstructured":"Hilleman, D. E., Malesker, M. A., Morrow, L. E. & Schuller, D. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 4, 253\u2013263 (2009).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201643_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000320221","volume":"80","author":"S Valente","year":"2010","unstructured":"Valente, S., Pasciuto, G., Bernabei, R. & Corbo, G. M. Do we need different treatments for very elderly COPD patients? Respiration 80, 357\u2013368 (2010).","journal-title":"Respiration"},{"key":"BFnpjpcrm201643_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/193168","volume":"2012","author":"A Vyas","year":"2012","unstructured":"Vyas, A., Pan, X. & Sambamoorthi, U. Chronic condition clusters and polypharmacy among adults. Int. J. Family Med. 2012, 1\u20138 (2012).","journal-title":"Int. J. Family Med."},{"key":"BFnpjpcrm201643_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.gerinurse.2015.05.003","volume":"36","author":"M Skinner","year":"2015","unstructured":"Skinner, M. A literature review: polypharmacy protocol for primary care. Geriatr. Nurs. 36, 367\u2013371.e4 (2015).","journal-title":"Geriatr. Nurs."},{"key":"BFnpjpcrm201643_CR57","first-page":"201","volume":"29","author":"NCH Stott","year":"1979","unstructured":"Stott, N. C. H. & Davis, R. H. The exceptional potential in each primary care consultation. J. R. Coll. Gen. Pract. 29, 201\u2013205 (1979).","journal-title":"J. R. Coll. Gen. Pract."},{"key":"BFnpjpcrm201643_CR58","unstructured":"Pendleton, D., Schofield, T., Tate, P. & Havelock, P. The Consultation: an Approach to Learning and Teaching (Oxford Univ. Press, Oxford, UK, 1984)."},{"key":"BFnpjpcrm201643_CR59","unstructured":"The Quality and Outcomes Framework. Health and Social Care Information Centre. Available at http:\/\/www.hscic.gov.uk\/qof. Accessed on April 2016."},{"key":"BFnpjpcrm201643_CR60","unstructured":"Gruffydd-Jones, K., Haughney, J., Jones, R., Loveridge, C. & Pinnock, H. Quick Guide to the Diagnosis and Management of COPD in Primary Care. Curdworth2014. Available at https:\/\/www.pcrs-uk.org\/resource\/Guidelines-and-guidance\/QGCOPD Accessed on April 2016."},{"key":"BFnpjpcrm201643_CR61","doi-asserted-by":"publisher","first-page":"h176","DOI":"10.1136\/bmj.h176","volume":"350","author":"E Wallace","year":"2015","unstructured":"Wallace, E. et al. Managing patients with multimorbidity in primary care. BMJ 350, h176 (2015).","journal-title":"BMJ"},{"key":"BFnpjpcrm201643_CR62","unstructured":"Gruffydd-Jones, K. & Poduval, S. Managing Multi-morbidity in Practice-What Lessons can be Learned from the Care of People with COPD and Multi-morbidities (Royal College of General Practitioners, 2013)."},{"key":"BFnpjpcrm201643_CR63","first-page":"CD006560","volume":"4","author":"SM Smith","year":"2012","unstructured":"Smith, S. M., Soubhi, H., Fortin, M., Hudon, C. & O\u2019Dowd, T. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst. Rev. 4, CD006560 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnpjpcrm201643_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12916-014-0223-1","volume":"12","author":"C Muth","year":"2014","unstructured":"Muth, C. et al. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med. 12, 223 (2014).","journal-title":"BMC Med."},{"key":"BFnpjpcrm201643_CR65","unstructured":"Mathers, N (chair). Royal College of General Practitioners. Clinical Innovation and Research Centre. Improving the Lives of People with Long Term Conditions (Royal College of General Practitioners, London, 2011)."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201643","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:17:57Z","timestamp":1672834677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,1]]}},"alternative-id":["BFnpjpcrm201643"],"URL":"https:\/\/doi.org\/10.1038\/npjpcrm.2016.43","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]},"assertion":[{"value":"17 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M. received royalties from the sale of the book cited in this article, the ABC of Multimorbidity. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16043"}}